Skip to Content

Cinoxacin Pregnancy and Breastfeeding Warnings

Cinoxacin is also known as: Cinobac

Cinoxacin Pregnancy Warnings

Cinoxacin has been assigned to category C. Animal studies have failed to reveal embryotoxicity or teratogenicity when cinoxacin was administered at doses up to 10 times doses normally given to humans. There are no controlled data in human pregnancy. Cartilage damage and arthropathies have been reported in immature animals, giving rise to concern over effects on fetal bone formation. Cinoxacin should not be given during pregnancy, unless the very rare clinical situation occurs where therapy is limited, and benefit outweighs risk.

See references

Cinoxacin Breastfeeding Warnings

It is not known whether cinoxacin is excreted in human milk. Cartilage damage and arthropathies have been reported in immature animals, giving rise to concern over adverse effects in a nursing infant. Cinoxacin use during lactation should be avoided until more data are available.

See references

References for pregnancy information

  1. "Product Information. Cinobac (cinoxacin)." Oclassen Pharmaceuticals Inc, San Rafael, CA.

References for breastfeeding information

  1. "Product Information. Cinobac (cinoxacin)." Oclassen Pharmaceuticals Inc, San Rafael, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide